[1]
Hoffmann, J.H. et al. 2021. Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio­markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles. Acta Dermato-Venereologica. 101, 5 (May 2021), adv00462. DOI:https://doi.org/10.2340/00015555-3814.